Patients with Parkinson’s disease (PD) suffer from a variety of movement disorders caused by a breakdown of brain neurons. While we don’t fully understand the causes of PD, we know that risk factors may include head trauma, genetics, exposure to toxins and heavy metals, and other issues, such as a sedentary lifestyle.

A study found that those with upper gastrointestinal damage are 76% more likely to develop Parkinson's disease, signaling a potential paradigm shift in how the disease is studied.

The “Parkinson’s Belt” is a series of regions in the U.S. with unusually high rates of the disease. Some scientists believe that environmental factors play a major role in who gets Parkinson’s.

Higher exposure to air pollution increases the risk for Parkinson's disease (PD), according to a study published online Sept. 16 in JAMA Network Open.

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 diabetes.

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By encouraging the kidneys to eliminate sugar from the body through urine, they reduce blood sugar.